Proteome Sciences plc announce Good Clinical Laboratory Practice Accreditation

Proteome Sciences are pleased to announce the receipt of Good Clinical Laboratory Practice (GCLP) accreditation which will enable the Company to extend its proteomic services to the analysis of clinical trial samples.

Proteome Sciences are a Contract Research Organisation (CRO) specialising in the analysis of proteins detected by Mass Spectrometry.  They offer various Discovery Services to characterise proteins and their associated post translational modifications.  By using LC-MS2, LC-MS3, SysQuant® and TMTcalibratorTM methodologies on samples that originate from tissue to biological fluids, they can detect many thousands of proteins per sample.  With their proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.

ELISA kits cover 5% of the human proteome, so there are usually no available assay kits to these disease relevant protein biomarkers.  The challenge has been how to convert these novel identified biomarkers into assays fit for use in a clinical trial.

Following identification above, Proteome Sciences can now a develop a targeted SRM Mass Spectrometry based assay which, after validation, can be used for fit-for-purpose biomarker assays in a GCLP certified clinical trial environment.  This can be done for one to 50 proteins in a single multiplexed assay.

For further information:

Richard Dennis, Chief Commercial Officer         Tel: +44 (0)20 7043 2116



OGT expands direct sales and support infrastructure in Europe

Customers to benefit from Sysmex’s extensive operational footprint

Read More >

Free Workshop – “FIT to Practice?” Alpha Laboratories at ACB FOCUS 2018

Faecal Immunochemical Testing (FIT) is now an established diagnostic test that identifies the presen...

Read More >

Expanding Global IVD Business Exhibits at the World’s Largest Lab Expo

BBI Solutions (BBI), a leading and rapidly expanding manufacturer of raw materials and finished test...

Read More >

A recent review by MIP Diagnostics Founder Sergey A. Piletsky from the University of Leicester and colleagues from Animal Health Research Institute

A recent review by MIP Diagnostics Founder Sergey A. Piletsky from the University of Leicester and c...

Read More >

Game Changer for Bladder Cancer Diagnosis

ADXBLADDER, an exciting new non-invasive test for bladder cancer from Arquer Diagnostics Ltd. and di...

Read More >

EKF launches pocket-sized lactate monitor for sports performance monitoring at MEDICA 2018

Cardiff, UK – 22nd October 2018 – EKF Diagnostics, the global in vitro diagnostics company, announ...

Read More >